Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06203938 · ClinicalTrials.gov registry record · NA

Autism Research Project With Non-Invasive Near-Infrared Light Stimulation

A NA study of Autism Spectrum Disorder, sponsored by University of Texas at Austin.

Recruiting
Registry status
NA
Development phase
280
Enrollment target
1
Study location

NCT06203938 is a NA study of Autism Spectrum Disorder that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 280 participants, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (109% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06203938, a NA study of Autism Spectrum Disorder, is actively recruiting participants, sponsored by University of Texas at Austin.

RECRUITING
Registry status
NA
Development phase
280 participants
Enrollment target
1
Study location

Study Summary

The investigators have previously shown that the administration of low-level infrared light is a safe and non-invasive procedure which improves cognition and emotion, as well as enhances brain metabolic activity. Based on previous studies, the investigators hypothesize that this methodology, called low-level light therapy or photobiomodulation, could be used to improve behavioral symptoms in individuals with autism spectrum disorder (ASD).

Conditions Studied

Interventions

  • DEVICE Sham
  • DEVICE Transcranial infrared light stimulation

Study Locations (1)

Texas

  • Seay Psychology Building, Room 3.304 - Austin

Trial Details

FieldValue
Enrollment Target 280 participants
Start Date 2025-01-13
Est. Completion 2027-12
Phase NA

Sponsor

University of Texas at Austin

257 total trials

What the Registry Record Tells You About NCT06203938

The ClinicalTrials.gov registry entry for NCT06203938 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (109% higher). The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.

NCT06203938 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06203938 about?

NCT06203938 is a clinical study titled "Autism Research Project With Non-Invasive Near-Infrared Light Stimulation". The investigators have previously shown that the administration of low-level infrared light is a safe and non-invasive procedure which improves cognition and emotion, as well as enhances brain metabolic activity. Based on previous studies, the investigators hypothesize that this methodology, called ...

What is the current status of trial NCT06203938?

This trial is currently recruiting. It is a NA study. The enrollment target is 280 participants. The study started on 2025-01-13. Estimated completion is 2027-12.

What conditions does trial NCT06203938 study?

This clinical trial studies the following conditions: Autism Spectrum Disorder.

What interventions are being tested in trial NCT06203938?

The interventions under investigation include: Sham (DEVICE), Transcranial infrared light stimulation (DEVICE).

Who is sponsoring clinical trial NCT06203938?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06203938 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism Spectrum Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.